Category : Search result: Karnataka FDA


FDA restricts children's supplement over health concerns

The US FDA has issued strict restrictions on a widely-used supplement for growing children after discovering serious health concerns. Find out which common product is now under scrutiny and what parents need to know.

BYV joins sugarcane farmers protest in Belagavi

Badal Vali Venkatagouda Patil joins forces with sugarcane farmers in Belagavi, amplifying protests against delayed payments and pressing for immediate government action on long-standing agricultural issues.

Nagalakshmi R. Kosumbe Appointed KCPCR Chairperson

In a significant development for child welfare in Karnataka, Nagalakshmi R. Kosumbe has been appointed as the new chairperson of the Karnataka Commission for Protection of Child Rights (KCPCR), bringing fresh leadership to the state's child protection ini

DK Shivakumar for Karnataka CM in 2028: Congress

Senior Congress leader Zameer Ahmed Khan declares DK Shivakumar as the party's chief ministerial candidate for 2028 Karnataka elections, sparking political discussions across the state.

FDA Approves Oral Weight Loss Drug Rybelsus

Breaking news: US FDA approves Rybelsus, the groundbreaking oral weight loss medication that mimics popular injection drugs. Discover how this pill could revolutionise obesity treatment in India and worldwide.

Elephant attack kills 2 in Kudremukh, Karnataka

A devastating wild elephant attack in Karnataka's Kudremukh region has left two people dead, highlighting the urgent human-wildlife conflict crisis. The victims were awaiting government rehabilitation when tragedy struck.

FDA Recalls 580K Blood Pressure Meds Over Cancer Risk

Major pharmaceutical recall alert: FDA discovers carcinogenic impurity in popular blood pressure medications, affecting hundreds of thousands of patients across the US. Safety concerns prompt immediate withdrawal.

RSS March Deadlock in Karnataka Continues

A crucial meeting between Muslim community leaders and officials in Karnataka's Chittapur has ended without consensus, leaving the controversial RSS march authorization in limbo. Get the latest updates on the ongoing standoff.

FDA OKs New Menopause Drug for Hot Flashes - November Launch

Breaking news: The FDA has approved Veozah (fezolinetant), a groundbreaking non-hormonal treatment for moderate to severe hot flashes during menopause. Discover how this game-changing medication works and when Indian women can access it.

FDA OKs First Non-Hormonal Menopause Drug

Breakthrough FDA approval offers new hope for women suffering from menopausal symptoms. Discover the first hormone-free oral medication that targets brain receptors for effective relief.

Page 1 of 4